H2020
RTCure
Rheuma Tolerance for Cure
- Programme
- Horizon 2020
- Started
- Ends
- Duration
- 72 months
- Total cost
- EUR 13,511,715
- EU contribution
- EUR 6,000,000
- Participants
- 18 from 10 countries
- Topic
- H2020_IMI2-2016-09-02
- Grant agreement
- 777357
Coordinated by Karolinska Institutet (SESweden).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Karolinska Institutet | SESweden | Coordinator | EUR 1,293,376 | known name (0.95) |
| Medizinische Universitaet Wien | ATAustria | Participant | EUR 446,725 | PIC (1.00) |
| The University of Queensland | AUAustralia | Participant | EUR 298,000 | PIC (1.00) |
| Apitope International NV | BEBelgium | Participant | EUR 169,337 | PIC (1.00) |
| Janssen Pharmaceutica NV | BEBelgium | Participant | EUR 0 | PIC (1.00) |
| Ucb Biopharma | BEBelgium | Participant | EUR 0 | PIC (1.00) |
| Fondazione Per L'Istituto di Ricerca in Biomedicina | CHSwitzerland | Participant | EUR 182,700 | PIC (1.00) |
| Deutsches Rheuma Forschungszentrumberlin | DEGermany | Participant | EUR 453,450 | PIC (1.00) |
| Sanofi-Aventis Deutschland GmbH | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Universitatsklinikum Erlangen | DEGermany | Participant | EUR 449,730 | known name (0.97) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| King's College London | GBUnited Kingdom | Participant | EUR 475,165 | known name (0.95) |
| The University of Birmingham | GBUnited Kingdom | Participant | EUR 448,075 | known name (0.95) |
| University of Glasgow | GBUnited Kingdom | Participant | EUR 448,725 | known name (0.95) |
| Semmelweis Egyetem | HUHungary | Participant | EUR 173,700 | known name (0.95) |
| Academisch Ziekenhuis Leiden | NLNetherlands | Participant | EUR 573,175 | PIC (1.00) |
| Anocca AB | SESweden | Participant | EUR 138,484 | PIC (1.00) |
| Bristol-Myers Squibb Company Corp | USUnited States | Participant | EUR 0 | PIC (1.00) |
Changes of the consortium
First seen on with 18 participants from 10 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.